Figure 4
Outcome by KIT gene mutations and treatments of t (8;21) AML patients. The comparison of (A,D) relapse, (B,E) DFS, and (C,F) OS between patients receiving hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
Outcome by KIT gene mutations and treatments of t (8;21) AML patients. The comparison of (A,D) relapse, (B,E) DFS, and (C,F) OS between patients receiving hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
